Chloe Song Distefano is a Brighton, Massachusetts based nurse practitioner. Active license number of Chloe Song Distefano is RN2331483 in Massachusetts. Her current practice location is 736 Cambridge St, Brighton. Patients can reach her at 617-789-3000. Chloe Song Distefano is MSN and her NPI number (Unique professional ID assigned by NPPES) is 1356119655. Chloe Song Distefano has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Chloe Song Distefano speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1356119655
NPI Enumeration Date:
15 Dec, 2023
NPI Last Update On:
13 Dec, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chloe Song Distefano are as mentioned below.
License Number
Specialization
State
Status
RN2331483
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Chloe Song Distefano 19 Forest Ave, Natick, Massachusetts
Zip:
01760-4856
Phone Number:
617-935-3520
Patients can reach Chloe Song Distefano at 736 Cambridge St, Brighton, Massachusetts or can call to book an appointment on 617-789-3000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.